Your browser doesn't support javascript.
loading
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Yadav, Udit; Kumar, Shaji K; Baughn, Linda B; Dispenzieri, Angela; Greipp, Patricia; Ketterling, Rhett; Jevremovic, Dragan; Buadi, Francis K; Dingli, David; Lacy, Martha Q; Fonseca, Rafael; Bergsagel, P Leif; Ailawadhi, Sikander; Roy, Vivek; Parrondo, Ricardo; Sher, Taimur; Hayman, Suzanne R; Kapoor, Prashant; Leung, Nelson; Cook, Joselle; Binder, Moritz; Muchtar, Eli; Warsame, Rahma; Kourelis, Taxiarchis V; Go, Ronald S; Lin, Yi; Seth, Abhishek; Lester, Scott C; Breen, William G; Kyle, Robert A; Gertz, Morie A; Rajkumar, S Vincent; Gonsalves, Wilson I.
Affiliation
  • Yadav U; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Baughn LB; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Greipp P; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Ketterling R; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Jevremovic D; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Fonseca R; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ.
  • Bergsagel PL; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ.
  • Ailawadhi S; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
  • Roy V; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
  • Parrondo R; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
  • Sher T; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
  • Hayman SR; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Leung N; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Cook J; Division of Nephrology, Mayo Clinic, Rochester, MN.
  • Binder M; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Muchtar E; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Kourelis TV; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Go RS; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Seth A; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Lester SC; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Breen WG; Department of Radiation Oncology, Mayo Clinic, Rochester, MN.
  • Kyle RA; Department of Radiation Oncology, Mayo Clinic, Rochester, MN.
  • Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Gonsalves WI; Division of Hematology, Mayo Clinic, Rochester, MN.
Blood ; 142(22): 1871-1878, 2023 11 30.
Article in En | MEDLINE | ID: mdl-37494698
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Plasmacytoma / Multiple Myeloma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2023 Type: Article Affiliation country: Mongolia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Plasmacytoma / Multiple Myeloma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2023 Type: Article Affiliation country: Mongolia